Keytruda
Vaccine May Help Reduce Relapse in High-Risk Melanoma Patients
2023-04-18 23:28:30
by
TWN Staff
ORLANDO, Fla. — A personalized mRNA-based cancer vaccine, when combined with Merck cancer therapy Keytruda, resulted in a statistically significant improvement in recurrence-free survival in people who had surgery to remove a cancerous tumor, compared with using Keytruda alone. That... Read More
Straight From The Well